Hepatitis in the News: Drug Collaboration Lags on Hepatitis Treatment (NYT)

“‘The only appropriate motivation should be what is the best and fastest way to get cures, not what is best for the shareholders,’ said Dr. Scott Friedman, chief of liver diseases at the Mount Sinai School of Medicine in New York…” Read more here.